Cloning, purification, kinetic and anion inhibition studies of a recombinant β-carbonic anhydrase from the Atlantic salmon parasite platyhelminth Gyrodactylus salaris

dc.contributor.authorAspatwar Ashok
dc.contributor.authorBarker Harlan
dc.contributor.authorAisala Heidi
dc.contributor.authorZueva Ksenia
dc.contributor.authorKuuslahti Marianne
dc.contributor.authorTolvanen Martti
dc.contributor.authorPrimmer Craig R
dc.contributor.authorLumme Jaakko
dc.contributor.authorBonardi Alessandro
dc.contributor.authorTripathi Amit
dc.contributor.authorParkkila Seppo
dc.contributor.authorSupuran Claudiu T
dc.contributor.organizationfi=biologian laitos|en=Department of Biology|
dc.contributor.organizationfi=terveysteknologia|en=Health Technology|
dc.contributor.organization-code1.2.246.10.2458963.20.28696315432
dc.contributor.organization-code2606400
dc.converis.publication-id175821691
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/175821691
dc.date.accessioned2025-08-28T02:16:58Z
dc.date.available2025-08-28T02:16:58Z
dc.description.abstract<p>A β-class carbonic anhydrase (CA, EC 4.2.1.1) was cloned from the genome of the Monogenean platyhelminth <i>Gyrodactylus salaris</i>, a parasite of Atlantic salmon. The new enzyme, GsaCAβ has a significant catalytic activity for the physiological reaction, CO<sub>2</sub> + H<sub>2</sub>O ⇋ HCO<sub>3</sub><sup>−</sup> + H<sup>+</sup> with a k<sub>cat</sub> of 1.1 × 10<sup>5</sup> s<sup>−1</sup> and a k<sub>cat</sub>/K<sub>m</sub> of 7.58 × 10<sup>6</sup> M<sup>−1</sup> × s<sup>−1</sup>. This activity was inhibited by acetazolamide (K<sub>I</sub> of 0.46 µM), a sulphonamide in clinical use, as well as by selected inorganic anions and small molecules. Most tested anions inhibited GsaCAβ at millimolar concentrations, but sulfamide (K<sub>I</sub> of 81 µM), N,N-diethyldithiocarbamate (K<sub>I</sub> of 67 µM) and sulphamic acid (K<sub>I</sub> of 6.2 µM) showed a rather efficient inhibitory action. There are currently very few non-toxic agents effective in combating this parasite. GsaCAβ is subsequently proposed as a new drug target for which effective inhibitors can be designed.</p>
dc.format.pagerange1577
dc.format.pagerange1586
dc.identifier.eissn1475-6374
dc.identifier.jour-issn1475-6366
dc.identifier.olddbid208848
dc.identifier.oldhandle10024/191875
dc.identifier.urihttps://www.utupub.fi/handle/11111/34893
dc.identifier.urlhttps://www.tandfonline.com/doi/full/10.1080/14756366.2022.2080818
dc.identifier.urnURN:NBN:fi-fe2022081154614
dc.language.isoen
dc.okm.affiliatedauthorZueva, Ksenia
dc.okm.affiliatedauthorTolvanen, Martti
dc.okm.discipline318 Medical biotechnologyen_GB
dc.okm.discipline318 Lääketieteen bioteknologiafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherTAYLOR & FRANCIS LTD
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.doi10.1080/14756366.2022.2080818
dc.relation.ispartofjournalJournal of Enzyme Inhibition and Medicinal Chemistry
dc.relation.issue1
dc.relation.volume37
dc.source.identifierhttps://www.utupub.fi/handle/10024/191875
dc.titleCloning, purification, kinetic and anion inhibition studies of a recombinant β-carbonic anhydrase from the Atlantic salmon parasite platyhelminth Gyrodactylus salaris
dc.year.issued2022

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
14756366.2022.pdf
Size:
3.44 MB
Format:
Adobe Portable Document Format